Heterocyclic compounds and uses thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9840503
SERIAL NO

15151259

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present disclosure relates to heterocyclic compounds, and pharmaceutical compositions of the same, that are inhibitors of the TAM protein kinases and are useful in the treatment of TAM-associated diseases such as cancer.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
INCYTE HOLDINGS CORPORATION1801 AUGUSTINE CUT-OFF WILIMINGTON DE 19803
INCYTE CORPORATION1801 AUGUSTINE CUT-OFF WILMINGTON DE 19803

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Burns, David M Glen Mills, US 83 1857
Li, Yun-Long Late of Chadds Ford, US 125 4544
Sun, Yaping Lansdale, US 31 804

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jun 12, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 12, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00